{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:47:55Z","timestamp":1784641675269,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2016R1A2B4014288"],"award-info":[{"award-number":["NRF-2016R1A2B4014288"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with asthma with obesity experience severe symptoms, are unresponsive to conventional asthma treatment, and lack proper pharmacotherapy. Empagliflozin and dulaglutide, developed for diabetes, reduce weight, decrease insulin resistance, and exert additive effects. We evaluated the efficacy of empagliflozin, dulaglutide, and their combination on obesity-induced airway hyperresponsiveness (AHR) and lung fibrosis using a murine model. We assigned C57BL\/6J mice to five groups: control, high-fat diet (HFD), and HFD with empagliflozin, dulaglutide, or both. Mice received a 12-week HFD, empagliflozin (5 days\/week, oral gavage), and dulaglutide (once weekly, intraperitoneally). Both drugs significantly attenuated HFD-induced weight increase, abnormal glucose metabolism, and abnormal serum levels of leptin and insulin, and co-treatment was more effective. Both drugs significantly alleviated HFD-induced AHR, increased macrophages in bronchoalveolar lavage fluid (BALF), and co-treatment was more effective on AHR. HFD-induced lung fibrosis was decreased by both drugs alone and combined. HFD induced interleukin (IL)-17, transforming growth factor (TGF)-<jats:italic>\u03b2<\/jats:italic>1, and IL-1<jats:italic>\u03b2<\/jats:italic> mRNA and protein expression, which was significantly reduced by empagliflozin, dulaglutide, and their combination. Tumour necrosis factor (TNF)-<jats:italic>\u03b1<\/jats:italic> and IL-6 showed similar patterns without significant differences. HFD-enhanced T helper (Th) 1 and Th17 cell differentiation was improved by both drugs. Empagliflozin and dulaglutide could be a promising therapy for obesity-induced asthma and showed additive effects in combination.<\/jats:p>","DOI":"10.1038\/s41598-019-51648-1","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T20:29:05Z","timestamp":1572467345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Empagliflozin and Dulaglutide are Effective against Obesity-induced Airway Hyperresponsiveness and Fibrosis in A Murine Model"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1862-1003","authenticated-orcid":false,"given":"Hye Jung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejae","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Yi","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Ryeol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0249-8749","authenticated-orcid":false,"given":"Jung-Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"issue":"5","key":"51648_CR1","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jaci.2004.11.050","volume":"115","author":"E FORD","year":"2005","unstructured":"Ford, E. S. The epidemiology of obesity and asthma. J. Allergy Clin. Immunol. 115, 897\u2013909; quiz 910, https:\/\/doi.org\/10.1016\/j.jaci.2004.11.050 (2005).","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"51648_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/thx.2007.082784","volume":"63","author":"B Taylor","year":"2008","unstructured":"Taylor, B. et al. Body mass index and asthma severity in the National Asthma Survey. Thorax 63, 14\u201320, https:\/\/doi.org\/10.1136\/thx.2007.082784 (2008).","journal-title":"Thorax"},{"key":"51648_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.metabol.2014.10.002","volume":"64","author":"LO Leiria","year":"2015","unstructured":"Leiria, L. O., Martins, M. A. & Saad, M. J. Obesity and asthma: beyond T(H)2 inflammation. Metabolism 64, 172\u2013181, https:\/\/doi.org\/10.1016\/j.metabol.2014.10.002 (2015).","journal-title":"Metabolism"},{"key":"51648_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/ajcn\/84.1.289","volume":"84","author":"BM Popkin","year":"2006","unstructured":"Popkin, B. M. Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases. Am. J. Clin. Nutr. 84, 289\u2013298, https:\/\/doi.org\/10.1093\/ajcn\/84.1.289 (2006).","journal-title":"Am. J. Clin. Nutr."},{"key":"51648_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1183\/09031936.06.00077205","volume":"27","author":"M Peters-Golden","year":"2006","unstructured":"Peters-Golden, M. et al. Influence of body mass index on the response to asthma controller agents. Eur. Respir. J. 27, 495\u2013503, https:\/\/doi.org\/10.1183\/09031936.06.00077205 (2006).","journal-title":"Eur. Respir. J."},{"key":"51648_CR6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/j.1398-9995.2012.02855.x","volume":"67","author":"ED Telenga","year":"2012","unstructured":"Telenga, E. D. et al. Obesity in asthma: more neutrophilic inflammation as a possible explanation for a reduced treatment response. Allergy 67, 1060\u20131068, https:\/\/doi.org\/10.1111\/j.1398-9995.2012.02855.x (2012).","journal-title":"Allergy"},{"key":"51648_CR7","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1136\/bmj.320.7238.827","volume":"320","author":"B Stenius-Aarniala","year":"2000","unstructured":"Stenius-Aarniala, B. et al. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 320, 827\u2013832 (2000).","journal-title":"BMJ"},{"key":"51648_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1381\/096089299765552981","volume":"9","author":"JB Dixon","year":"1999","unstructured":"Dixon, J. B., Chapman, L. & O\u2019Brien, P. Marked improvement in asthma after Lap-Band surgery for morbid obesity. Obes. Surg. 9, 385\u2013389 (1999).","journal-title":"Obes. Surg."},{"key":"51648_CR9","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1183\/09031936.00053413","volume":"43","author":"SA Dias-Junior","year":"2014","unstructured":"Dias-Junior, S. A. et al. Effects of weight loss on asthma control in obese patients with severe asthma. Eur. Respir. J. 43, 1368\u20131377, https:\/\/doi.org\/10.1183\/09031936.00053413 (2014).","journal-title":"Eur. Respir. J."},{"key":"51648_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1165\/rcmb.2015-0345OC","volume":"55","author":"HJ Park","year":"2016","unstructured":"Park, H. J. et al. Roflumilast Ameliorates Airway Hyperresponsiveness Caused by Diet-Induced Obesity in a Murine Model. Am. J. Respir. Cell. Mol. Biol. 55, 82\u201391, https:\/\/doi.org\/10.1165\/rcmb.2015-0345OC (2016).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"51648_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/17425255.2017.1258401","volume":"13","author":"B Tomlinson","year":"2017","unstructured":"Tomlinson, B., Hu, M., Zhang, Y., Chan, P. & Liu, Z. M. Evaluation of the pharmacokinetics, pharmacodynamics and clinical efficacy of empagliflozin for the treatment of type 2. diabetes. Expert Opin. Drug Metab. Toxicol. 13, 211\u2013223, https:\/\/doi.org\/10.1080\/17425255.2017.1258401 (2017).","journal-title":"diabetes. Expert Opin. Drug Metab. Toxicol."},{"key":"51648_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.7326\/M15-1432","volume":"164","author":"F Zaccardi","year":"2016","unstructured":"Zaccardi, F., Htike, Z. Z., Webb, D. R., Khunti, K. & Davies, M. J. Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis. Ann. Intern. Med. 164, 102\u2013113, https:\/\/doi.org\/10.7326\/M15-1432 (2016).","journal-title":"Ann. Intern. Med."},{"key":"51648_CR13","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2174\/1381612824666180604113653","volume":"24","author":"M Doumas","year":"2018","unstructured":"Doumas, M. et al. Combination of SGLT-2 Inhibitors and GLP-1 Receptor Agonists: Potential Benefits in Surrogate and Hard Endpoints. Curr. Pharm. Des. 24, 1879\u20131886, https:\/\/doi.org\/10.2174\/1381612824666180604113653 (2018).","journal-title":"Curr. Pharm. Des."},{"key":"51648_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1152\/japplphysiol.00847.2006","volume":"102","author":"SA Shore","year":"2007","unstructured":"Shore, S. A. Obesity and asthma: lessons from animal models. J. Appl. Physiol. 102, 516\u2013528, https:\/\/doi.org\/10.1152\/japplphysiol.00847.2006 (2007).","journal-title":"J. Appl. Physiol."},{"key":"51648_CR15","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3349\/ymj.2013.54.6.1430","volume":"54","author":"SH Jung","year":"2013","unstructured":"Jung, S. H. et al. Effects of diet-induced mild obesity on airway hyperreactivity and lung inflammation in mice. Yonsei Med. J. 54, 1430\u20131437, https:\/\/doi.org\/10.3349\/ymj.2013.54.6.1430 (2013).","journal-title":"Yonsei Med. J."},{"key":"51648_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-017-0719-9","volume":"17","author":"HA Scott","year":"2017","unstructured":"Scott, H. A., Wood, L. G. & Gibson, P. G. Role of Obesity in Asthma: Mechanisms and Management Strategies. Curr. Allergy Asthma Rep. 17, 53, https:\/\/doi.org\/10.1007\/s11882-017-0719-9 (2017).","journal-title":"Curr. Allergy Asthma Rep."},{"key":"51648_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1165\/rcmb.2008-0415OC","volume":"41","author":"BD Medoff","year":"2009","unstructured":"Medoff, B. D. et al. Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am. J. Respir. Cell. Mol. Biol. 41, 397\u2013406, https:\/\/doi.org\/10.1165\/rcmb.2008-0415OC (2009).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"51648_CR18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1164\/rccm.201203-0573OC","volume":"186","author":"O Sideleva","year":"2012","unstructured":"Sideleva, O. et al. Obesity and asthma: an inflammatory disease of adipose tissue not the airway. Am. J. Respir. Crit. Care. Med. 186, 598\u2013605, https:\/\/doi.org\/10.1164\/rccm.201203-0573OC (2012).","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"51648_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/5584_2018_152","volume":"1070","author":"KF Mobaireek","year":"2018","unstructured":"Mobaireek, K. F. et al. Hyperglycemia in Children Hospitalized with Acute Asthma. Adv. Exp. Med. Biol. 1070, 19\u201325, https:\/\/doi.org\/10.1007\/5584_2018_152 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"51648_CR20","doi-asserted-by":"publisher","first-page":"E1016","DOI":"10.1152\/ajpendo.00329.2010","volume":"299","author":"M Spencer","year":"2010","unstructured":"Spencer, M. et al. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am. J. Physiol. Endocrinol. Metab. 299, E1016\u20131027, https:\/\/doi.org\/10.1152\/ajpendo.00329.2010 (2010).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"51648_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17558-w","volume":"7","author":"DM Andre","year":"2017","unstructured":"Andre, D. M. et al. High-fat diet-induced obesity impairs insulin signaling in lungs of allergen-challenged mice: Improvement by resveratrol. Sci. Rep. 7, 17296, https:\/\/doi.org\/10.1038\/s41598-017-17558-w (2017).","journal-title":"Sci. Rep."},{"key":"51648_CR22","doi-asserted-by":"publisher","first-page":"L837","DOI":"10.1152\/ajplung.00091.2015","volume":"310","author":"S Singh","year":"2016","unstructured":"Singh, S. et al. Hyperinsulinemia adversely affects lung structure and function. Am. J. Physiol. Lung Cell. Mol. Physiol. 310, L837\u2013845, https:\/\/doi.org\/10.1152\/ajplung.00091.2015 (2016).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"51648_CR23","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3904\/kjim.2017.207","volume":"33","author":"L Liang","year":"2018","unstructured":"Liang, L. et al. Effect of the anti-IL-17 antibody on allergic inflammation in an obesity-related asthma model. Korean J. Intern. Med. 33, 1210\u20131223, https:\/\/doi.org\/10.3904\/kjim.2017.207 (2018).","journal-title":"Korean J. Intern. Med."},{"key":"51648_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm.3423","volume":"20","author":"HY Kim","year":"2014","unstructured":"Kim, H. Y. et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat. Med. 20, 54\u201361, https:\/\/doi.org\/10.1038\/nm.3423 (2014).","journal-title":"Nat. Med."},{"key":"51648_CR25","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1055\/s-0034-1395609","volume":"47","author":"A Ojima","year":"2015","unstructured":"Ojima, A., Matsui, T., Nishino, Y., Nakamura, N. & Yamagishi, S. Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis. Horm. Metab. Res. 47, 686\u2013692, https:\/\/doi.org\/10.1055\/s-0034-1395609 (2015).","journal-title":"Horm. Metab. Res."},{"key":"51648_CR26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.diabet.2017.10.007","volume":"44","author":"T Kimura","year":"2018","unstructured":"Kimura, T. et al. Durability of protective effect of dulaglutide on pancreatic beta-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure. Diabetes Metab. 44, 250\u2013260, https:\/\/doi.org\/10.1016\/j.diabet.2017.10.007 (2018).","journal-title":"Diabetes Metab."},{"key":"51648_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000471765","volume":"3","author":"B Satirapoj","year":"2017","unstructured":"Satirapoj, B. Sodium-Glucose Cotransporter 2 Inhibitors with Renoprotective Effects. Kidney Dis. 3, 24\u201332, https:\/\/doi.org\/10.1159\/000471765 (2017).","journal-title":"Kidney Dis."},{"key":"51648_CR28","doi-asserted-by":"publisher","first-page":"L856","DOI":"10.1152\/ajplung.00386.2005","volume":"290","author":"FL Lu","year":"2006","unstructured":"Lu, F. L. et al. Increased pulmonary responses to acute ozone exposure in obese db\/db mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L856\u2013865, https:\/\/doi.org\/10.1152\/ajplung.00386.2005 (2006).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"51648_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1056\/NEJMe1706095","volume":"377","author":"EW Gregg","year":"2017","unstructured":"Gregg, E. W. & Shaw, J. E. Global Health Effects of Overweight and Obesity. N. Engl. J. Med. 377, 80\u201381, https:\/\/doi.org\/10.1056\/NEJMe1706095 (2017).","journal-title":"N. Engl. J. Med."},{"key":"51648_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3349\/ymj.2017.58.1.187","volume":"58","author":"C Chang","year":"2017","unstructured":"Chang, C. et al. Costs Attributable to Overweight and Obesity in Working Asthma Patients in the United States. Yonsei Med. J. 58, 187\u2013194, https:\/\/doi.org\/10.3349\/ymj.2017.58.1.187 (2017).","journal-title":"Yonsei Med. J."},{"key":"51648_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/DMSO.S154602","volume":"11","author":"TS Cavaiola","year":"2018","unstructured":"Cavaiola, T. S. & Pettus, J. Cardiovascular effects of sodium glucose cotransporter 2 inhibitors. Diabetes Metab. Syndr. Obes. 11, 133\u2013148, https:\/\/doi.org\/10.2147\/DMSO.S154602 (2018).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"51648_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.12.027","volume":"94","author":"HJL Heerspink","year":"2018","unstructured":"Heerspink, H. J. L., Kosiborod, M., Inzucchi, S. E. & Cherney, D. Z. I. Renoprotective effects of sodium-glucose cotransporter-2 inhibitors. Kidney Int. 94, 26\u201339, https:\/\/doi.org\/10.1016\/j.kint.2017.12.027 (2018).","journal-title":"Kidney Int."},{"key":"51648_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/14740338.2018.1428305","volume":"17","author":"A Consoli","year":"2018","unstructured":"Consoli, A., Formoso, G., Baldassarre, M. P. A. & Febo, F. A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment. Expert Opin. Drug Saf. 17, 293\u2013302, https:\/\/doi.org\/10.1080\/14740338.2018.1428305 (2018).","journal-title":"Expert Opin. Drug Saf."},{"issue":"4","key":"51648_CR34","doi-asserted-by":"publisher","first-page":"1041-1047.e3","DOI":"10.1016\/j.jaci.2012.09.028","volume":"131","author":"Ruby Fernandez-Boyanapalli","year":"2013","unstructured":"Fernandez-Boyanapalli, R. et al. Obesity impairs apoptotic cell clearance in asthma. J. Allergy Clin. Immunol. 131, 1041\u20131047, 1047 e1041\u20131043, https:\/\/doi.org\/10.1016\/j.jaci.2012.09.028 (2013).","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"51648_CR35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1440-1843.2011.02080.x","volume":"17","author":"CS Farah","year":"2012","unstructured":"Farah, C. S. & Salome, C. M. Asthma and obesity: a known association but unknown mechanism. Respirology 17, 412\u2013421, https:\/\/doi.org\/10.1111\/j.1440-1843.2011.02080.x (2012).","journal-title":"Respirology"},{"issue":"3","key":"51648_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/brainsci9030057","volume":"9","author":"Melvin Hayden","year":"2019","unstructured":"Hayden, M. R., Grant, D. G., Aroor, A. R. & DeMarco, V. G. Empagliflozin Ameliorates Type 2 Diabetes-Induced Ultrastructural Remodeling of the Neurovascular Unit and Neuroglia in the Female db\/db Mouse. Brain Sci. 9, https:\/\/doi.org\/10.3390\/brainsci9030057 (2019).","journal-title":"Brain Sciences"},{"key":"51648_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbrc.2019.01.103","volume":"511","author":"M Zhou","year":"2019","unstructured":"Zhou, M. et al. Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3beta. Biochem. Biophys. Res. Commun. 511, 154\u2013160, https:\/\/doi.org\/10.1016\/j.bbrc.2019.01.103 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"51648_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2015.50","volume":"47","author":"HJ Park","year":"2015","unstructured":"Park, H. J. et al. Acute exposure to silica nanoparticles aggravate airway inflammation: different effects according to surface characteristics. Exp. Mol. Med. 47, e173, https:\/\/doi.org\/10.1038\/emm.2015.50 (2015).","journal-title":"Exp. Mol. Med."},{"key":"51648_CR39","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/jcmm.12102","volume":"17","author":"JH Lee","year":"2013","unstructured":"Lee, J. H. et al. A novel human anti\u2010VCAM\u20101 monoclonal antibody ameliorates airway inflammation and remodelling. J. Cell. Mol. Med. 17, 1271\u20131281 (2013).","journal-title":"J. Cell. Mol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51648-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51648-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51648-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:13:47Z","timestamp":1671290027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51648-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["51648"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-51648-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"assertion":[{"value":"11 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15601"}}